EPIPAGE2 Cohort Study Follow up at Five and a Half Years
-
- STATUS
- Not Recruiting
-
- participants needed
- 5201
-
- sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
Nawel ms AFROUKH, MD
Primary Contact
CH Valence (1.1 mi away) Contact
+72 other locationSummary
Epipage 2 (epidemiologic study on small-for-gestational-age children) is a nationwide study implemented to improve our knowledge of the outcome of preterm children in France. This study was launched on March 28, 2011 and includes three groups of preterm children, all born before 35 weeks: extremely preterm infants (born between 22 and 26 completed weeks of gestation), very preterm children (born between 27 and 31 completed weeks) and moderately preterm children (born between 32 and 34 completed weeks).
These children are being studied from their birth up to the age of 12 years. At birth, data on maternal and infants' characteristics were collected from medical records. At one and two years, questionnaires sent to families and to physicians (at two years only) allowed to collect data about the children's life and health.
At five and a half years, medical and psychological assessments are specifically implemented for the study in order to evaluate motor and cognitive disorders in this population.
Details
| Treatment | Medical and neuropsychological assessments |
|---|---|
| Clinical Study Identifier | NCT03078439 |
| Sponsor | Institut National de la Santé Et de la Recherche Médicale, France |
| Last Modified on | 22 January 2021 |
Adding a note
Select a piece of text and start making personal notes.
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer